Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies
Emily Merkel(Seattle Pacific University), Ann Dahlberg(Seattle Children's Hospital), Paul A. Carpenter(Fred Hutch Cancer Center), Scott N. Furlan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ted Gooley(Fred Hutch Cancer Center), Todd M. Cooper(Seattle Children's Hospital), Corinne Summers(Seattle Children's Hospital), Brandon Hadland(Seattle Children's Hospital), Katherine Tarlock(Center for Cancer and Blood Disorders), Danielle Kirkey(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lauri M. Burroughs(Fred Hutch Cancer Center), Robert G. Irwin(Mary Bridge Children's Health Center), Ross Goshorn(Providence Sacred Heart Medical Center), Monica S. Thakar(Fred Hutch Cancer Center), Aleksandra Petrović(Seattle Children's Hospital), Marie Bleakley(Unknown)
Cited by 0
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma
|Biology of Blood and Marrow Transplantation|2008|264
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|247